Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma

PaperCitations, authors & open-access status

VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 64 citations, 2017 year and diamond oa status.

64
Citations
2017
Year
diamond
OA Status

Related on ScholarIQ

Zhou Wang
Author
Oncotarget
Journal
Cancer-related Molecular Pathways
Topic
Cancer-related Molecular Pathways
Topic
Genetic factors in colorectal cancer
Topic
Nuclear Structure and Function
Topic
470M+ articles · free account